SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $316,000 | +22.0% | 2,000 | 0.0% | 0.03% | +18.5% |
Q1 2024 | $258,920 | +6.8% | 2,000 | 0.0% | 0.03% | -6.9% |
Q3 2023 | $242,440 | +5.9% | 2,000 | 0.0% | 0.03% | +7.4% |
Q2 2023 | $229,040 | -16.9% | 2,000 | 0.0% | 0.03% | -20.6% |
Q1 2023 | $275,660 | +6.4% | 2,000 | 0.0% | 0.03% | +3.0% |
Q4 2022 | $259,160 | +17.3% | 2,000 | 0.0% | 0.03% | +10.0% |
Q3 2022 | $221,000 | -35.2% | 2,000 | 0.0% | 0.03% | -48.3% |
Q4 2020 | $341,000 | +21.4% | 2,000 | 0.0% | 0.06% | +5.5% |
Q3 2020 | $281,000 | -12.5% | 2,000 | 0.0% | 0.06% | -20.3% |
Q2 2020 | $321,000 | +24.4% | 2,000 | 0.0% | 0.07% | +27.8% |
Q4 2019 | $258,000 | -15.1% | 2,000 | 0.0% | 0.05% | -27.0% |
Q2 2019 | $304,000 | +27.7% | 2,000 | 0.0% | 0.07% | +21.3% |
Q1 2019 | $238,000 | +0.4% | 2,000 | 0.0% | 0.06% | -9.0% |
Q4 2018 | $237,000 | -59.6% | 2,000 | -50.0% | 0.07% | -16.2% |
Q3 2018 | $587,000 | +122.3% | 4,000 | +100.0% | 0.08% | +8.1% |
Q2 2018 | $264,000 | – | 2,000 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 87,180 | $2,581,000 | 3.60% |
Perceptive Advisors | 1,771,029 | $52,422,000 | 2.99% |
SPHERA FUNDS MANAGEMENT LTD. | 483,047 | $14,298,000 | 2.80% |
HealthCor Management, L.P. | 1,550,000 | $45,880,000 | 2.10% |
Camber Capital Management LP | 1,350,000 | $39,960,000 | 1.62% |
Tourbillon Capital Partners, L.P. | 1,537,518 | $45,511,000 | 1.17% |
Elk Creek Partners, LLC | 562,522 | $16,651,000 | 1.02% |
EMERALD ADVISERS, LLC | 818,705 | $24,234,000 | 1.00% |
EMERALD MUTUAL FUND ADVISERS TRUST | 604,467 | $17,892,000 | 0.82% |
Carlson Capital, L.P. | 1,845,702 | $54,633,000 | 0.70% |